Phase II Trial Of Neoadjuvant Bevacizumab with Modified FOLFOX7 in Patients with Stage II and III Rectal Cancer
Barzi, Afsaneh, Choi, April, TsaoâWei, Denice, Iqbal, Syma, ElâKhoueiry, Anthony, Agafitei, Dana Raluca, Cologne, Kyle Graham, Lenz, HeinzâJosefJournal:
The Oncologist
DOI:
10.1634/theoncologist.2020-0642
Date:
July, 2020
File:
PDF, 535 KB
2020